Dr. Domokos Gero graduated as an MD at the Semmelweis University Medical School in 2000 and also received his Ph.D. degree at Semmelweis University. In 2000, he started transgenic mouse research in Dr. Mozes’ laboratory focusing on gene therapeutic approaches against renal fibrosis at the Pathophysiology Department of Semmelweis University, then from 2006, he started working on cell-based drug screening projects after he joined the CellScreen Research Center at the University. In 2010, he was invited to lead the cell-based drug screening group in Dr. Csaba Szabo’s lab and became a faculty of the Department of Anesthesiology, the University of Texas Medical Branch (UTMB), USA, and continued his work there in early drug discovery projects. In 2015 he moved to the UK, receiving a Marie Curie fellowship, and joined the University of Exeter Medical School, Devon, UK for 2 years working with Dr. Matt Whiteman on further characterization of mitochondrial hydrogen-sulfide donors. Since 2017, he has been teaching at the Institute of Translational Medicine, Semmelweis University Medical School, Hungary, and started his own cell-based screening laboratory. He has published over 50 research papers.